Insights & News

Patrick Kelly Presents at BioStrategy Partners Practical Knowledge Series

January 14, 2022
Firm News
PHILADELPHIA – Stradley Ronon is pleased to announce that counsel and member of the firm’s intellectual property group, Patrick J. Kelly, Ph.D., presented at the inaugural 2022 BioStrategy Partners Practical Knowledge Series on Jan. 14. An experienced life science patent attorney, Kelly joined a leading panel of specialists discussing the fundamentals of creating and building a startup for an invention. The group also provided a comprehensive insight into the current state of startups in the biotech industry.

BioStrategy Partners, Inc. is a 501c3 nonprofit consortium of academic medical centers and research institutes committed to developing and transferring academic research into the marketplace.

Kelly focuses his practice on intellectual property matters and has experience serving as an advisor to pharmaceutical, biotech and scientific instrumentation companies in all aspects of patent law. He has handled preparing and prosecuting patent applications, formulating and maintaining biotech intellectual property estates, due diligence, freedom-to-operate studies and licensing. Kelly has also represented pharmaceutical companies in intellectual property litigation matters, including patent infringement and abbreviated new drug applications.

About Stradley Ronon
Counseling clients since 1926, Stradley Ronon has helped private and public companies – from small businesses to Fortune 500 corporations – achieve their goals by providing pragmatic, value-driven legal counsel. With offices in seven strategic locations, our responsive team of more than 200 attorneys seamlessly addresses the full spectrum of our clients’ needs, ranging from sophisticated corporate transactions to complex commercial litigation.

Related Services

Related Resources

back to top